These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 18580615)
1. Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. Cook JA; Burke-Miller JK; Cohen MH; Cook RL; Vlahov D; Wilson TE; Golub ET; Schwartz RM; Howard AA; Ponath C; Plankey MW; Levine AM; Grey DD AIDS; 2008 Jul; 22(11):1355-63. PubMed ID: 18580615 [TBL] [Abstract][Full Text] [Related]
2. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. Baum MK; Rafie C; Lai S; Sales S; Page B; Campa A J Acquir Immune Defic Syndr; 2009 Jan; 50(1):93-9. PubMed ID: 19295339 [TBL] [Abstract][Full Text] [Related]
3. Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study. Martel-Laferrière V; Nitulescu R; Cox J; Cooper C; Tyndall M; Rouleau D; Walmsley S; Wong L; Klein MB; BMC Infect Dis; 2017 Jan; 17(1):80. PubMed ID: 28095797 [TBL] [Abstract][Full Text] [Related]
4. Crack cocaine use increases the incidence of AIDS-defining events in French Guiana. Nacher M; Adenis A; Hanf M; Adriouch L; Vantilcke V; El Guedj M; Vaz T; Dufour J; Couppié P AIDS; 2009 Oct; 23(16):2223-6. PubMed ID: 19752716 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study. Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020 [TBL] [Abstract][Full Text] [Related]
6. Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. Sharpe TT; Lee LM; Nakashima AK; Elam-Evans LD; Fleming PL J Community Health; 2004 Apr; 29(2):117-27. PubMed ID: 15065731 [TBL] [Abstract][Full Text] [Related]
7. Crack cocaine: effect modifier of RNA viral load and CD4 count in HIV infected African American women. Duncan R; Shapshak P; Page JB; Chiappelli F; McCoy CB; Messiah SE Front Biosci; 2007 Jan; 12():1488-95. PubMed ID: 17127396 [TBL] [Abstract][Full Text] [Related]
8. Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study. Hayashi K; Wood E; Kerr T; Dong H; Nguyen P; Puskas CM; Guillemi S; Montaner JS; Milloy MJ BMC Infect Dis; 2016 Aug; 16(1):455. PubMed ID: 27568002 [TBL] [Abstract][Full Text] [Related]
9. Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use. Socías ME; Wood E; Small W; Dong H; Shoveller J; Kerr T; Montaner J; Milloy MJ Drug Alcohol Depend; 2016 Nov; 168():211-218. PubMed ID: 27701042 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis B and long-term HIV outcomes in coinfected HAART recipients. Hoffmann CJ; Seaberg EC; Young S; Witt MD; D'Acunto K; Phair J; Thio CL AIDS; 2009 Sep; 23(14):1881-9. PubMed ID: 19550291 [TBL] [Abstract][Full Text] [Related]
11. Streets, drugs, and the economy of sex in the age of AIDS. Weeks MR; Grier M; Romero-Daza N; Puglisi-Vasquez MJ; Singer M Women Health; 1998; 27(1-2):205-29. PubMed ID: 9640643 [TBL] [Abstract][Full Text] [Related]
12. Experience of pain among women with advanced HIV disease. Richardson JL; Heikes B; Karim R; Weber K; Anastos K; Young M AIDS Patient Care STDS; 2009 Jul; 23(7):503-11. PubMed ID: 19534600 [TBL] [Abstract][Full Text] [Related]
13. Correlates of antiretroviral utilization among hospitalized HIV-infected crack cocaine users. Doshi RK; Vogenthaler NS; Lewis S; Rodriguez A; Metsch L; del Rio C AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1007-14. PubMed ID: 22214200 [TBL] [Abstract][Full Text] [Related]
14. The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy. Anastos K; Barrón Y; Cohen MH; Greenblatt RM; Minkoff H; Levine A; Young M; Gange SJ Ann Intern Med; 2004 Feb; 140(4):256-64. PubMed ID: 14970148 [TBL] [Abstract][Full Text] [Related]
15. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. Vlahov D; Graham N; Hoover D; Flynn C; Bartlett JG; Margolick JB; Lyles CM; Nelson KE; Smith D; Holmberg S; Farzadegan H JAMA; 1998 Jan; 279(1):35-40. PubMed ID: 9424041 [TBL] [Abstract][Full Text] [Related]
16. Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States. Murphy K; Hoover DR; Shi Q; Cohen M; Gandhi M; Golub ET; Gustafson DR; Pearce CL; Young M; Anastos K AIDS; 2013 Sep; 27(15):2413-23. PubMed ID: 24037210 [TBL] [Abstract][Full Text] [Related]
17. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study. Anastos K; Kalish LA; Hessol N; Weiser B; Melnick S; Burns D; Delapenha R; DeHovitz J; Cohen M; Meyer W; Bremer J; Kovacs A AIDS; 1999 Sep; 13(13):1717-26. PubMed ID: 10509574 [TBL] [Abstract][Full Text] [Related]